, ,

ReLASV® Pan-Lassa Prefusion GP IgG ELISA Kit – RUO (10201) – Special Order


Designation: Semi-quantitative detection of anti-LASV glycoprotein (GP) neutralizing human IgG antibodies
Clade specificity: Pan-Lassa, antibodies to lineages II, III, IV glycoprotein (GP) antigens
Applications: ELISA microplate
Storage: 2-8°C
Shipping: Refrigerated; blue ice packs

Ordering: Item 10201 is a special order product, and inventory may be limited. Contact Zalgen for current status and projected availability.

This assay is a direct ELISA detecting Human IgG antibody specific for LASV Prefusion GP. Diluted samples, Reference, and Negative Control are incubated in microwells coated with a mixture of recombinant LASV Prefusion GP antigens. Incubation allows the anti-LASV antibody present in the samples to react with the immobilized antigen mixture. After the removal of unbound serum or plasma proteins by washing, anti-human IgG antibodies, labeled with horseradish peroxidase (HRP), are added forming complexes with the bound IgG anti-LASV antibody. Following another washing step, the bound enzyme-antibody conjugate is assayed by the addition of TMB substrate. Color develops in the wells at an intensity proportional to the concentration of IgG anti-LASV antibody in the sample. Optical Density (O.D.) results are obtained by reading the absorbance (A450nm minus A620nm) using an ELISA plate reader. It is recommended that the user establish a cut-off for the study population using LASV sero-negative samples. It is also recommended that LF IgG positive convalescent LF samples from the study population be included in each assay as an additional reference sample.

Package insert for ReLASV Pan-Lassa PFGP IgG ELISA kit (RUO) – pdf



Shopping Cart
Scroll to Top